Marius Piepke

IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke.

T. Arumugam, C. Sobey, M. Gelderblom, 2018, JCI insight.

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response

C. Gerloff, T. Renné, R. Flavell, 2021, Journal of Neuroinflammation.

Interleukin-1 Mediates Ischemic Brain Injury via Induction of IL-17A in γδ T Cells and CXCL1 in Astrocytes

M. Gelderblom, K. Lambertsen, B. Clausen, 2022, NeuroMolecular Medicine.

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response

C. Gerloff, T. Renné, R. Flavell, 2021, Journal of Neuroinflammation.

A preclinical randomized controlled multi-centre trial of anti-interleukin-17A treatment for acute ischaemic stroke

C. Gerloff, J. Sedlacik, T. Arumugam, 2023, Brain communications.